SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ImmunoGen
IMGN 31.230.0%Feb 26 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Sonny who wrote (3661)11/5/2000 5:14:27 PM
From: Gary Mohilner  Read Replies (1) of 5665
 
Sonny,

While I don't disagree with you per se, I believe MTSL will raise their numbers when IMGN gives them something to base their price on. To date, they've pretty much known what was going to happen, and it's happened, new partnerships and Analysts coverage. What's happening now wasn't forecast, a major stock offering, and they don't know precisely what will be presented by Dr. Tolcher and company. I believe when the presentation and offering have been concluded, depending on how they're received, MTSL will raise their numbers substantially.

The next MTSL should be out the Friday after the Annual Meeting. If information posted on R.B. is correct, that's the same week the offering will be made. If IMGN's price does not falter, I believe that would be a reasonable time for establishing new prices. I know some will say this sounds like hype, but I wouldn't be surprised if the buy under price comes up to $75 and the target goes to $150, JMHO.

Gary
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext